Literature DB >> 19766294

Role of NMDA receptor in homocysteine-induced activation of mitogen-activated protein kinase and phosphatidyl inositol 3-kinase pathways in cultured human vascular smooth muscle cells.

Gabriella Doronzo1, Isabella Russo, Paola Del Mese, Michela Viretto, Luigi Mattiello, Mariella Trovati, Giovanni Anfossi.   

Abstract

INTRODUCTION: Exposure of vascular smooth muscle cells (VSMC) to homocysteine, at concentrations associated with an increased risk of cardiovascular events, enhances synthesis and secretion of Matrix Metalloproteinase-2 (MMP-2), which is involved in atherosclerotic plaque instabilization. This effect was prevented by inhibitors of Mitogen Activated Protein Kinase (MAPK) and Phosphatidylinositol 3-Kinase (PI3-K) pathways, allowing to hypothesize that homocysteine activates both these pathways, likely via a receptor-mediated mechanism. One possible receptor is N-methyl-D-aspartate receptor (NMDAr), which is expressed in VSMC and is involved in homocysteine effects in other cell types.
MATERIALS AND METHODS: VSMC exposed to DL-homocysteine or NMDA (100 micromol/L for both; 5 min-8 hours), were investigated by measuring: i) phosphorylation of ERK1/2, p38MAPK (signaling molecules of MAPK pathway) and Akt and p70S6K (signaling molecules of PI3-K pathway) by western blot; ii) synthesis and secretion of MMP-2 (western blot); iii) activation of MMP-2 (gelatin zimography). To evaluate NMDAr involvement in the homocysteine effects, the experiments were repeated in the presence of a non-competitive NMDAr-antagonist MK-801 (50 micromol/L) or L-glycine (10 micromol/L), which inhibits NMDAr function by promoting its internalization.
RESULTS: DL-homocysteine and NMDA time-dependently increased: i) the phosphorylation of ERK1/2, p38 MAPK, Akt and p70S6K (ANOVA, p<0.0001); ii) the synthesis, secretion and activation of MMP-2. DL-homocysteine and NMDA effects were prevented by VSMC pre-incubation with MK-801 or high L-glycine concentrations.
CONCLUSIONS: In human VSMC homocysteine-at concentrations associated with increased cardiovascular risk- activates MAPK and PI3-K pathways and MMP-2 synthesis and secretion through NMDA receptor, a potential mechanism involved in intracellular signaling in response to homocysteine in VSMC. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19766294     DOI: 10.1016/j.thromres.2009.08.015

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  10 in total

1.  Enhanced vascular PI3K/Akt-NOX signaling underlies the peripheral NMDAR-mediated pressor response in conscious rats.

Authors:  Marie A McGee; Abdel A Abdel-Rahman
Journal:  J Cardiovasc Pharmacol       Date:  2014-05       Impact factor: 3.105

2.  Epigallocatechin gallate protects against homocysteine-induced vascular smooth muscle cell proliferation.

Authors:  Xiao Li Zhan; Xiu Hong Yang; Yan Hong Gu; Li Li Guo; Hui Min Jin
Journal:  Mol Cell Biochem       Date:  2017-09-04       Impact factor: 3.396

3.  NMDA receptor-mediated activation of NADPH oxidase and glomerulosclerosis in hyperhomocysteinemic rats.

Authors:  Chun Zhang; Fan Yi; Min Xia; Krishna M Boini; Qing Zhu; Laura A Laperle; Justine M Abais; Christopher A Brimson; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2010-10-01       Impact factor: 8.401

4.  Hydrogen Sulfide Epigenetically Attenuates Homocysteine-Induced Mitochondrial Toxicity Mediated Through NMDA Receptor in Mouse Brain Endothelial (bEnd3) Cells.

Authors:  Pradip K Kamat; Anuradha Kalani; Suresh C Tyagi; Neetu Tyagi
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

5.  Emodin Inhibits Homocysteine-Induced C-Reactive Protein Generation in Vascular Smooth Muscle Cells by Regulating PPARγ Expression and ROS-ERK1/2/p38 Signal Pathway.

Authors:  Xiaoming Pang; Juntian Liu; Yuxia Li; Jingjing Zhao; Xiaolu Zhang
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

6.  NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice.

Authors:  Xiang Xie; Chuang Luo; Jia Yu Liang; Run Huang; Jia Li Yang; Linlong Li; YangYang Li; Hongming Xing; Huan Chen
Journal:  PeerJ       Date:  2021-07-07       Impact factor: 2.984

7.  Effects of direct Renin inhibition on myocardial fibrosis and cardiac fibroblast function.

Authors:  Hui Zhi; Ivan Luptak; Gaurav Alreja; Jianru Shi; Jian Guan; Nicole Metes-Kosik; Jacob Joseph
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

8.  Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation.

Authors:  Todd D Prickett; Brad J Zerlanko; Victoria K Hill; Jared J Gartner; Nouar Qutob; Jiji Jiang; May Simaan; John Wunderlich; J Silvio Gutkind; Steven A Rosenberg; Yardena Samuels
Journal:  J Invest Dermatol       Date:  2014-04-16       Impact factor: 8.551

Review 9.  Epigenetic Regulation of Oxidative Stress in Ischemic Stroke.

Authors:  Haiping Zhao; Ziping Han; Xunming Ji; Yumin Luo
Journal:  Aging Dis       Date:  2016-05-27       Impact factor: 6.745

10.  How does binding of agonist ligands control intrinsic molecular dynamics in human NMDA receptors?

Authors:  Zoltan Palmai; Kimberley Houenoussi; Sylvia Cohen-Kaminsky; Luba Tchertanov
Journal:  PLoS One       Date:  2018-08-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.